Recruitment Materials

Purpose of Study

Medication abortion via the drug mifepristone is a safe, effective practice available in over 60 countries. In 2017 Canadian nursing regulators and Health Canada implemented changes that would allow nurse practitioners (NPs) to provide mifepristone. This study seeks to understand the experiences of NPs with medication abortion in order to improve the implementation of this practice amongst NPs, with the potential to improve access for marginalized, rural and remote communities in Canada.

Eligibility

Eligible to participate are NPs in Canada who currently provide, intend to provide, OR do not intend to provide medical abortion in their practice.

Click on the hyperlinks below for recruitment posters available in English and French.

Study Summary
Study Flyer – English
Study Flyer – French
Consent statement – English
Consent statement – French